Inhibrx Biosciences, Inc.
USD93.63
-5.66 (-5.70%)
CEO
Mark Paul Lappe
IPO Date
2024-06-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$96.51
Prev. Close
$99.29
Day Low
$89.10
Day High
$99.44
52W Low
$12.80
52W High
$155.29
Market Cap
$1.37B
Volume
0.32M
| 308,643 |
| $32.25 |
| 9 Oct 2025 | VIKING GLOBAL INVESTORS LP | 10 percent owner | S-Sale | Disposed | 16,315 | $32.25 |
| 9 Oct 2025 | VIKING GLOBAL INVESTORS LP | 10 percent owner | S-Sale | Disposed | 25,042 | $32.25 |
| 29 May 2025 | MANHARD KIMBERLY | director | A-Award | Acquired | 15,000 | $12.91 |
| 29 May 2025 | Vuori Kristiina MD | director | A-Award | Acquired | 15,000 | $12.91 |
| 29 May 2025 | Kayyem Jon Faiz | director | A-Award | Acquired | 15,000 | $12.91 |
| 29 May 2025 | FORSYTH DOUGLAS | director | A-Award | Acquired | 15,000 | $12.91 |
| 2 Apr 2025 | Deck Kelly | Chief Financial Officer | A-Award | Acquired | 15,000 | $14.05 |
| 28 Mar 2025 | Kayyem Jon Faiz | director | G-Gift | Disposed | 90,000 | $0.00 |